Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Sonoma Pharmaceuticals Inc.

TRADE

NASDAQ: SNOAHealthcare / Drug Manufacturers - Other / USA
1.98-0.03-1.49%Vol 14 2481Y Perf -63.33%
Aug 15th, 2018 11:56
BID1.96 ASK1.98
Open2.00 Previous Close2.01
Pre-Market- After-Trading-
 - -%  - -%
Target Price
5.00 
Analyst Rating
Moderate Buy 1.67
Potencial %
152.53 
Finscreener Ranking
★★★★+     59.64
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
★★★★     57.82
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
★★+     48.23
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)13 
Earnings Rating
Price Range Ratio 52wk %
9.61 
Earnings Date

Today's Price Range

1.962.02

 

52wk Range

1.565.93

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-18.95%
3 Months
-47.24%
6 Months
-54.93%
1 Year
-63.33%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
SNOA1.98-0.0300-1.49
AAPL208.54-1.2100-0.58
GOOG1 212.96-29.1400-2.35
MSFT107.27-2.2900-2.09
XOM76.92-1.3900-1.77
WFC58.00-0.0700-0.12
JNJ129.650.15000.12
FB176.30-4.8100-2.66
GE12.16-0.1900-1.54
JPM113.54-1.1100-0.97
...

TickerPriceChg.%52 Week High
CMG520.185.44521.40
KMB115.523.95124.15
BSX34.612.7037.30
PCG43.752.1271.57
CLX144.712.02150.40
PGR63.501.9464.77
HCP26.791.9430.59
EIX68.241.8883.38
LUV60.171.8366.99
ARE126.771.82134.37
ED79.871.7289.70
HSY100.311.72115.82
VTR58.331.5069.92
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.60
Current Ratio 5.00
Long Term Debt to Total Capital 0.01
Total Debt to Equity 0.04
Interest Coverage -357.20
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin43.90
EBIT Margin-85.80
EBITDA Margin-82.80
Pre-tax Profit Margin-75.20
Profit Margin-84.38
ValuationValueIndustryS&P 500US Markets
PE Ratio 2.70
PB Ratio 0.97
PS Ratios 1.16
Price to Cash Flow 10.50
Price to Free Cash Flow -1.90
Cash Flow Per Share -2.75
Price to Tangible Book0.97
Book Value per Share2.37
Enterprise Value (in ths.)5 339
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-30.10
ROE last 12 Months -77.96
Return on Assets (5Y Avg) -17.63
ROA last 12 Months -64.16
Return on Capital (5Y Avg) -24.99
ROC last 12 Months -68.82
Return on invested Capital Q -32.30
Return on invested Capital Y-77.13
Assets Turnover0.20
Receivables Turnover2.40
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)12 823
Revenue per Share 1.99
Revenue Growth 3 Years 5.19
Revenue Growth 5 Years 2.97
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2019--0.55-
Q04 2018-0.65-0.93-43.08
Q03 2018-0.63-0.73-15.87
Q02 2018-0.75-0.6710.67
Q01 2017--0.61-
Q04 2016--0.16-
Q03 2016--0.19-
Q02 2016-0.14-0.1121.43
Earnings Per EndEstimateRevision %Trend
3/2018 QR-0.650.00-
3/2018 QR-0.6014.29Positive
3/2018 FY-2.860.00-
3/2019 FY-2.200.00-
Next Report Date14th Aug 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume14 248
Shares Outstanding (in ths.)6 460
Trades Count15
Dollar Volume19 936
Avg. Volume93 480
Avg. Weekly Volume117 239
Avg. Monthly Volume62 810
Avg. Quarterly Volume79 214

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

62%38%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
1 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.67
Moderate Buy
1.67
Moderate Buy
2.00

There are no comments yet.

News

x